N-{4-nitro-3-[4-(4-nitrophenyl)piperazin-1-yl]phenyl}ethane-1,2-diamine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: N-{4-nitro-3-[4-(4-nitrophenyl)piperazin-1-yl]phenyl}ethane-1,2-diamine
• 英文别名: N'-[4-nitro-3-[4-(4-nitrophenyl)piperazin-1-yl]phenyl]ethane-1,2-diamine
• 化学式: C18H22N6O4
• 分子量: 386.4
• InChiKey: UUUDGYSOXSEQLK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  28
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  136
• 氢给体数：
  2
• 氢受体数：
  8

文献信息

• US6194399B1
  申请人：——

  公开号：US6194399B1

  公开（公告）日：2001-02-27
• [EN] ARYLDIAMINE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS<br/>[FR] DERIVES D'ARYLDIAMINE UTILES COMME AGENTS ANTIBACTERIENS
  申请人：SCRIPTGEN PHARM INC

  公开号：WO2000021539A1

  公开（公告）日：2000-04-20

  Disclosed are pharmaceutical compositions and formulations having compound (I) wherein: (a) R1, R2, R3, and R4 are independently selected from the group consisting of hydrogen, branched or straight-chained C1 to C12 alkyl, aryl, vinyl, alkyl(aryl), vinyl(aryl), primary, secondary, or tertiary amine, amide; (b) X is hydrogen, NO2, CN, halogen, OH, SO2, branched or straight-chained C1-C6 alkyl, alkoxy, or vinyl, positioned on the aromatic ring at any of positions 2, 4, 5 or 6; (c) wherein when R1, R2, R3, and R4 are branched or straight-chained C1 to C12 alkyl, aryl, vinyl, alkyl(aryl), vinyl(aryl), primary, secondary, or tertiary amine or amide, R1, R2, R3, and R4 are optionally interrupted with at least one heteroatom, or optionally substituted with a hydroxy, halogen, nitro, thrihalomethyl group, carbonyl moiety, a substituted or unsubstituted, branched or straight-chained C1 to C12 alkyl, aryl, vinyl, alkyl(aryl), vinyl(aryl), primary, secondary, or tertiary amine, hydrazone, alkoxy, or aryloxy; and (d) R1, R2, R3, and R4 are branched or straight-chained C1 to C12 alkyl, aryl, vinyl, alkyl(aryl), vinyl(aryl), primary, secondary, or tertiary amine or amide, optionally at least one of R1 and R2, together, and R3 and R4, together, form a ring system, wherein the ring system is optionally interrupted by at least one heteroatom, and optionally substituted with a hydroxy, halogen, nitro, trihalomethyl group, carbonyl moiety, C1 to C12 alkyl, primary, secondary, or tertiary amine, alkoxy, or aryloxy; or a salt thereof, and a pharmaceutically acceptable carrier or diluent. Also disclosed are methods of inhibiting bacterial growth.